Aktiesnakken — Oktober 2012
-
Mornings
-
godmorgen
-
Rituxan i ny stor fremgang på 11% http://borsen.dk/nyheder/investor/artikel/1/243479/roche_med_lidt_bedre_salg_end_ventet_i_tredje_kvartal.html
-
Annualiseret svarer dette til 6,7 mia. CHF !!!
-
Ved nuværende CHF kurs svarer det til et årligt salg på 41 mia kr. Prøv at forestille jer at Arzerra lige tog 20-25% royalty af den kage
-
om 2-3år...
-
2018 min ven
-
Morning
-
Ja 1989, det bliver en lang tur op ad bakke
-
Så er J&J aktierne også gået igennem og optaget til handel
-
82-82,5 nu i genmab
-
-
ja og vi har rettet genmabs nøgletal
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind